![](/img/cover-not-exists.png)
Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
Rugo, H. S., Stopeck, A. T., Joy, A. A., Chan, S., Verma, S., Lluch, A., Liau, K. F., Kim, S., Bycott, P., Rosbrook, B., Bair, A. H., Soulieres, D.Volume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.31.2975
Date:
June, 2011
File:
PDF, 144 KB
english, 2011